Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B (Q40623032)
Jump to navigation
Jump to search
scientific article published on October 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B |
scientific article published on October 1, 2003 |
Statements
1 reference
Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B (English)
Lianne Fuino
1 reference
Purva Bali
1 reference
Sylvie Wittmann
1 reference
Sreenivas Donapaty
1 reference
Fei Guo
1 reference
Hirohito Yamaguchi
1 reference
Hong-Gang Wang
1 reference
Peter Atadja
1 reference
1 October 2003
1 reference
1 reference